Skorpios Trust - Significant Ownership

Signature - Title
Androulla Papadopoulou - Director
Location
Limassol, Cyprus
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Skorpios Trust.

Significant Ownership of Skorpios Trust

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
STOK Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share 13% $58.8M 6.91M Skorpios Trust Dec 23, 2024

Schedules 13D/G Reported by Skorpios Trust:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.